These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37047137)

  • 21. Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders.
    Wu X; Daniels T; Molinaro C; Lilly MB; Casiano CA
    Cell Death Differ; 2002 Sep; 9(9):915-25. PubMed ID: 12181742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor.
    Wang H; Jurado KA; Wu X; Shun MC; Li X; Ferris AL; Smith SJ; Patel PA; Fuchs JR; Cherepanov P; Kvaratskhelia M; Hughes SH; Engelman A
    Nucleic Acids Res; 2012 Dec; 40(22):11518-30. PubMed ID: 23042676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of small peptides inhibiting the integrase-LEDGF/p75 interaction through targeting the cellular co-factor.
    Cavalluzzo C; Christ F; Voet A; Sharma A; Singh BK; Zhang KY; Lescrinier E; De Maeyer M; Debyser Z; Van der Eycken E
    J Pept Sci; 2013 Oct; 19(10):651-8. PubMed ID: 24014475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of the ternary complex formed by c-Myc interactor JPO2, transcriptional co-activator LEDGF/p75, and chromatin.
    Hendrix J; van Heertum B; Vanstreels E; Daelemans D; De Rijck J
    J Biol Chem; 2014 May; 289(18):12494-506. PubMed ID: 24634210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region.
    De Rijck J; Bartholomeeusen K; Ceulemans H; Debyser Z; Gijsbers R
    Nucleic Acids Res; 2010 Oct; 38(18):6135-47. PubMed ID: 20484370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
    Mediavilla-Varela M; Pacheco FJ; Almaguel F; Perez J; Sahakian E; Daniels TR; Leoh LS; Padilla A; Wall NR; Lilly MB; De Leon M; Casiano CA
    Mol Cancer; 2009 Aug; 8():68. PubMed ID: 19715609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding.
    Busschots K; Vercammen J; Emiliani S; Benarous R; Engelborghs Y; Christ F; Debyser Z
    J Biol Chem; 2005 May; 280(18):17841-7. PubMed ID: 15749713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators.
    Canella A; Van Belle S; Brouns T; Nigita G; Carlon MS; Christ F; Debyser Z
    Cancer Gene Ther; 2022 Feb; 29(2):133-140. PubMed ID: 33795806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of LEDGF/p75 genetic variants and association with HIV-1 disease progression.
    Messiaen P; De Spiegelaere W; Alcami J; Vervisch K; Van Acker P; Verhasselt B; Meuwissen P; Calonge E; Gonzalez N; Gutierrez-Rodero F; Rodriguez-Martín C; Sermijn E; Poppe B; Vogelaers D; Verhofstede C; Vandekerckhove L
    PLoS One; 2012; 7(11):e50204. PubMed ID: 23226247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase.
    Cherepanov P; Devroe E; Silver PA; Engelman A
    J Biol Chem; 2004 Nov; 279(47):48883-92. PubMed ID: 15371438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase.
    Llano M; Delgado S; Vanegas M; Poeschla EM
    J Biol Chem; 2004 Dec; 279(53):55570-7. PubMed ID: 15475359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
    Cermáková K; Tesina P; Demeulemeester J; El Ashkar S; Méreau H; Schwaller J; Rezáčová P; Veverka V; De Rijck J
    Cancer Res; 2014 Sep; 74(18):5139-51. PubMed ID: 25082813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells.
    Schrijvers R; Vets S; De Rijck J; Malani N; Bushman FD; Debyser Z; Gijsbers R
    Retrovirology; 2012 Oct; 9():84. PubMed ID: 23046603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ.
    Bartholomeeusen K; Christ F; Hendrix J; Rain JC; Emiliani S; Benarous R; Debyser Z; Gijsbers R; De Rijck J
    J Biol Chem; 2009 Apr; 284(17):11467-77. PubMed ID: 19244240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter.
    Singh DP; Bhargavan B; Chhunchha B; Kubo E; Kumar A; Fatma N
    PLoS One; 2012; 7(5):e37012. PubMed ID: 22615874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering.
    Hendrix J; Gijsbers R; De Rijck J; Voet A; Hotta J; McNeely M; Hofkens J; Debyser Z; Engelborghs Y
    Nucleic Acids Res; 2011 Mar; 39(4):1310-25. PubMed ID: 20974633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of serine residues 271, 273, and 275 in the human immunodeficiency virus type 1 cofactor activity of lens epithelium-derived growth factor/p75.
    Garcia-Rivera JA; Bueno MT; Morales E; Kugelman JR; Rodriguez DF; Llano M
    J Virol; 2010 Jan; 84(2):740-52. PubMed ID: 19889764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model.
    Vets S; Kimpel J; Volk A; De Rijck J; Schrijvers R; Verbinnen B; Maes W; Von Laer D; Debyser Z; Gijsbers R
    Mol Ther; 2012 May; 20(5):908-17. PubMed ID: 22334021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
    Chen WM; Liu XY
    Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins.
    Levin A; Rosenbluh J; Hayouka Z; Friedler A; Loyter A
    Mol Med; 2010; 16(1-2):34-44. PubMed ID: 19855849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.